Copyright
©The Author(s) 2016.
World J Gastroenterol. Dec 14, 2016; 22(46): 10226-10231
Published online Dec 14, 2016. doi: 10.3748/wjg.v22.i46.10226
Published online Dec 14, 2016. doi: 10.3748/wjg.v22.i46.10226
All patients | Non-cirrhotics | Cirrhotics | ||||||||||
GT1 | GT2 | GT3 | P value | GT1 | GT2 | GT3 | P value | GT1 | GT2 | GT3 | P value | |
T Chol | 5.3 | 0.1 | 16.1 | 0.017 | 5.8 | -0.4 | 12.8 | 0.066 | 5.0 | 0.7 | 20.1 | 0.39 |
HDL | 12.3 | 2.0 | 7.9 | 0.049 | 18.2 | 0.5 | 11.1 | 0.008 | 7.6 | 4.0 | 4.0 | 0.69 |
LDL | -5.9 | -1.1 | -11.9 | 0.550 | 4.6 | 1.0 | 8.1 | 0.150 | 9.7 | 0.3 | 17.9 | 0.82 |
TG | 7.4 | 2.1 | 21.2 | 0.130 | -5.7 | 3.4 | -12.6 | 0.650 | -6.1 | -9.0 | -6.4 | 0.76 |
- Citation: Pedersen MR, Patel A, Backstedt D, Choi M, Seetharam AB. Genotype specific peripheral lipid profile changes with hepatitis C therapy. World J Gastroenterol 2016; 22(46): 10226-10231
- URL: https://www.wjgnet.com/1007-9327/full/v22/i46/10226.htm
- DOI: https://dx.doi.org/10.3748/wjg.v22.i46.10226